Defines when the study is stopped for efficacy at interim.
Two options are available: "all" stops the trial
if the efficacy criterion is fulfilled for all selected treatment arms/populations,
"atLeastOne" stops if at least one of the selected treatment arms/populations is shown to be
superior to control at interim, default is "all".